Epithalon’s long-term human safety profile is not well characterized, which makes clinician selection especially important. Your clinician will review cancer history, pregnancy status, medications, and other hormone or growth-factor-oriented treatments before prescribing it. The telomerase-related mechanism is biologically meaningful and is still being actively studied. Newer cell research has shown telomere-lengthening pathways in both normal and cancer cell lines, highlighting why long-term implications should not be oversimplified. With injections, local irritation, bruising, or swelling can occur.